drugset / Trial / NCT00860964

A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

NCT00860964

Phase 4 Completed 221 enrolled Peking Union Medical College
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this trial is to study the efficacy and safety of low dose of estradiol valerate in the prevention and treatment of postmenopausal osteoporosis.

Timeline

Start
1998-02
Primary completion
2003-02
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject estradiol valerate Unknown 1 mg
Comparator Calcium carbonate Other / unclassified 900 mg
Comparator VitD Unknown 200 iu
Background medroxyprogesterone acetate Other / unclassified 6 mg

Indications